Section Editors

Chantal Mathieu - Professor of Medicine, Catholic University Leuven

Chantal Mathieu

Professor of Medicine, Catholic University Leuven

Dr. Mathieu’s basic research interest is in prevention of Type 1 diabetes and non-classical effects of Vitamin D.

Dr. Mathieu has authored more than 300 articles in peer reviewed journals and was Associate editor and a member of the Advisory Board for Diabetologia. She is a member of the Research Council of Flanders and is a member of the European Association for the Study of Diabetes, the American Diabetes Association, IDS and former President of the Flemish Diabetes Association.

Linda Siminerio, RN, PhD, CDE - Executive Director, University of Pittsburgh Diabetes Institute

Linda Siminerio, RN, PhD, CDE

Executive Director, University of Pittsburgh Diabetes Institute

Dr. Siminerio’s primary research topics include diabetes education, diabetes translation into community interventions, pediatric diabetes care and education, and the psychosocial and behavioral aspects of diabetes.

Dr. Siminerio is the author of numerous books and scientific publications in her field and is the author of the National Standards for Diabetes Education and the International Diabetes Standards and Curriculum.

She is a nationally prominent advocate for diabetes care, education and funding, and is a former Vice President of the ADA. She is the Chair of the International Diabetes Federation (IDF) translation research program and served as Chair of the IDF World Congress.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Andre Scheen discusses the CVD-REAL study and findings. Support: The filming of this video was supported by AstraZeneca.
Simon Heller talks about his highlights from EASD 2017 and the latest developments in the field of diabetes.
Stefano Del Prato discusses the use of DPP-4 inhibitors and vildagliptin in special patient populations. Read more in European Endocrinology here. Support: The filming of this video was supported by Novartis. Stefano Del Prato has received research support from AstraZeneca, MSD, Novartis and Boehringer Ingelheim, and consultancy fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, GSK,...